Entries tagged "Eli Lilly and Co."

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Eli Lilly and Co.."

6 result(s) displayed (1 - 6 of 6)

Carlyle exits Qualicaps

Mitsubishi Chemical pays $654 million for the maker of pharmaceutical capsules. Continue reading

Posted on December 26, 2012 11:47 AM

After drug's collapse, all eyes on Elan

The pharmaceutical company's share price is buoyed by takeover speculation after its Alzheimer's compound fails a clinical trial Continue reading

Posted on August 8, 2012 9:08 AM

ShangPharma gets takeout bid from CEO Hui and TPG

The Shanghai biotech services provider weighs a $8.50 to $9.50 per share bid for the 35% that the buyers don't already own Continue reading

Posted on July 9, 2012 9:39 AM

Amylin target of renewed M&A murmurs

The end of the drug company's partnership with Eli Lilly spurs speculation of other Big Pharma interest. Continue reading

Posted on November 10, 2011 8:23 AM

Eli Lilly, Amylin end diabetes partnership

The drugmakers end a collaboration that has been marred by litigation between the two companies Continue reading

Posted on November 8, 2011 11:07 AM

Lilly to rely on R&D, not M&A

To cope with patent expirations that will cost it billions of dollars in sales over the next six years, Eli Lilly rolled out a plan to put its innovation to the test and rely on its own drug development. Continue reading

Posted on July 1, 2011 3:13 PM

Movable Type search results powered by Fast Search